尼古丁口香糖市场规模、份额、成长分析、按类型、分销管道、按地区 - 行业预测，2024-2031

Nicotine Gum Market Size, Share, Growth Analysis, By Type (2mg, and 4mg), By Distribution Channel (Supermarkets/hypermarkets, Convenience stores), By Region - Industry Forecast 2024-2031

出版日期: 2024年10月01日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年尼古丁口香糖的全球市场规模为13亿美元，从2023年的13.7亿美元成长到2031年的21.2亿美元，预计复合年增长率为5.6%。

美国尼古丁口香糖市场是 FDA 批准的戒烟辅助剂，由于寻求戒烟的人数显着增加，预计未来几年将持续成长。这种口香糖可以与尼古丁贴片一起使用，以缓解戒断症状或在需要时对抗强烈的渴望，透过口腔黏膜释放尼古丁并有效抑制尼古丁衝动。最初受到 COVID-19 封锁的影响，世界卫生组织 (WHO) 和疾病管制与预防中心 (CDC) 等卫生组织强调了戒烟对于降低与病毒相关的健康风险的重要性。人们越来越意识到吸烟对健康的负面影响，进一步推动了戒烟产品的普及。随着越来越多的吸烟者意识到与吸烟习惯相关的风险，尼古丁口香糖作为抑制吸烟渴望的美味且易于使用的解决方案的吸引力可能会推动市场成长。消费行为的这些变化，加上持续不断的倡导戒烟的公共卫生宣传活动，正在引领尼古丁口香糖产业在竞争激烈的健康市场中持续扩张。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Johnson & Johnson（US）
Novartis AG（Switzerland）
ITC Limited（India）
Cipla Health Limited（India）
Perrigo Company Plc（Ireland）
Teva Canada（Canada）
Philip Morris International Inc.（US）
British American Tobacco PLC（UK）
GlaxoSmithKline plc（UK）
Novartis Consumer Health（Germany）
Fertin Pharma（Denmark）
Alchem International（India）
Revolymer（UK）
Pfizer Inc.（US）
Cambrex Corporation（US）
Reynolds American（US）
Takeda Pharmaceutical Company（Japan）

简介目录

Product Code: SQSG35I2048

Global Nicotine Gum Market size was valued at USD 1.30 billion in 2022 and is poised to grow from USD 1.37 billion in 2023 to USD 2.12 billion by 2031, growing at a CAGR of 5.6% in the forecast period (2024-2031).

The US nicotine gum market, an FDA-approved smoking cessation aid, is set to experience sustainable growth in the coming years, driven by a notable increase in individuals seeking to quit smoking. This gum, which can be used in conjunction with nicotine patches to alleviate withdrawal symptoms or to combat stronger cravings as needed, releases nicotine through the mouth lining, effectively suppressing the urge for nicotine. Although initially impacted by COVID-19 lockdowns, there has been a resurgence in demand as health organizations like the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) have emphasized the importance of quitting smoking to mitigate health risks associated with the virus. Rising awareness of the detrimental health effects of smoking has further fueled the push for cessation products. As more smokers recognize the dangers associated with their habits, the appeal of nicotine gum as a flavorful, accessible solution to curb cravings will drive market growth. This shift in consumer behavior, along with ongoing public health campaigns advocating for smoking cessation, positions the nicotine gum sector for sustained expansion in the competitive wellness market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nicotine Gum market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nicotine Gum Market Segmental Analysis

Global Nicotine Gum Market is segmented on the basis of type, distribution channel, and region. By type, market is segmented into 2mg, and 4mg. By distribution channel, market is segmented into supermarkets/hypermarkets, convenience stores, pharmacies, and online. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Nicotine Gum Market

The increasing prevalence of diseases linked to tobacco use, such as lung cancer, heart disease, and respiratory ailments, serves as a significant market driver for the global nicotine gum market. As public awareness of the health risks associated with smoking grows, individuals are seeking effective cessation aids to combat their addiction and safeguard their health. Nicotine gum provides a trusted and convenient method for smokers to manage cravings and reduce withdrawal symptoms, thus promoting healthier lifestyles. Consequently, the escalating global tobacco crisis is intensifying the demand for nicotine replacement therapies, positioning nicotine gum as a crucial solution in public health efforts to reduce smoking-related morbidity and mortality.

Restraints in the Global Nicotine Gum Market

The Global Nicotine Gum market faces significant restraints due to the common adverse reactions associated with its use, which include high blood pressure, rapid heart rate, dizziness, insomnia, and gastrointestinal issues such as nausea and indigestion. These side effects can deter potential users from adopting nicotine gum as a smoking cessation aid, as individuals may be hesitant to experience discomfort or health complications. Additionally, the risk of experiencing prolonged adverse effects from frequent chewing can further discourage usage, ultimately suppressing market growth during the forecast period as consumers exercise caution in seeking alternatives for nicotine replacement therapies.

Market Trends of the Global Nicotine Gum Market

The global nicotine gum market is poised for significant growth in the coming years, driven by heightened health awareness and a collective shift towards healthier lifestyles. Increased government focus on reducing smoking rates through comprehensive tobacco control measures-including bans on advertising, promotion, and the gradual escalation of tobacco taxes-will bolster demand for nicotine replacement therapies. These initiatives, combined with efforts to limit smoking in workplaces and public areas, are expected to not only curtail the prevalence of smoking but also encourage smokers to seek alternatives like nicotine gum, ultimately expanding the market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree Of Competition
Top Investment Pockets
Ecosystem Of the Market
Value Chain Analysis
Raw Material Analysis
Pricing Analysis
Consumer Behaviour Analysis
PESTLE Analysis

Nicotine Gum Market, By Type

Market Overview
2mg
4mg

Nicotine Gum Market, By Distribution Channel

Market Overview
Supermarkets/hypermarkets
Convenience stores
Pharmacies
Online

Nicotine Gum Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ITC Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla Health Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perrigo Company Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Canada (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philip Morris International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
British American Tobacco PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis Consumer Health (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fertin Pharma (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alchem International (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revolymer (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cambrex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reynolds American (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments